For cardiologists and cardiac surgeons managing aortic aneurysms
For physician consultation only. Not intended as medical advice for individual patients.
The evidence base for aortic dissection risk is well-established. The problem is consistent application: different physicians weight risk factors differently, apply different mental models, or rely on diameter alone. The result is the variability patients encounter — three consultations, three different risk numbers — which reflects a delivery failure, not a scientific one.
A standardized, evidence-based risk report — applying the same multipliers to every patient, producing the same result regardless of which physician enters the data, and generating a timestamped clinical record — addresses this directly. It supports shared decision-making, strengthens the surgical timing conversation, and creates a defensible documentation trail.
Aortic Sciences delivers exactly this: a physician-facing clinical decision support platform grounded in Elefteriades/Davies, IRAD outcomes, and ACC/AHA 2022 thresholds — generating individualized 30-year dissection risk projections at the point of care. No EMR required.
A 3% annual dissection risk is abstract. Projected forward — accounting for continued aortic growth of approximately 0.07 cm/year (Elefteriades/Davies) and the resulting progression through higher-risk diameter brackets — the cumulative picture becomes both more accurate and more actionable.
A patient today at 4.8 cm with hypertension and BAV does not face a static annual risk. Over the next decade, as that aorta grows, annual event probability climbs into successively higher brackets. The 10-year cumulative risk may be multiples of today's estimate — making watchful waiting appear far less conservative than the current snapshot suggests. A year-by-year trajectory transforms an abstract percentage into a concrete decision support tool.
Acute Type A aortic dissection carries a 30-day operative mortality of 21–25% at experienced centers, per IRAD data across 7,300+ cases. Elective ascending aortic repair at those same centers: 1–2%. That gap — 10 to 20 times — is the central argument for timely, individualized risk assessment.
The window between surveillance and surgery is where outcome is determined. A patient converted from watchful waiting to planned elective repair faces a fundamentally different risk profile than the same patient who presents in dissection. ACC/AHA 2022 guidelines encode this logic into intervention thresholds — but thresholds alone don't account for the full individual risk picture.
Diameter alone is an insufficient basis for surgical timing. Each of the following independently compounds the baseline rate established by aortic size:
A hypertensive male in his mid-60s with BAV and a family history of dissection carries an aggregate risk profile that diverges sharply from a diameter-only assessment. Multiplicative risk modeling captures what a single measurement cannot.
Schedule a 20-minute demo of the Aortic Sciences physician portal — secure, browser-based, no EMR required.
For physician consultation only. Not intended as medical advice for individual patients. Aortic Sciences.